Barclays Maintains an 'Overweight' on Dr Pepper Snapple (DPS); On the Road to Recovery
Tweet Send to a Friend
Barclays maintains an 'Overweight' on Dr Pepper Snapple (NYSE: DPS), PT $42.
Barclays analyst says, "We maintain our above Consensus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "We maintain our above Consensus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
